itolizumab (103)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGG LVKPGGSLKL SCAASGFKFS RYAMSWVRQA PGKRLEWVAT  50

ISSGGSYIYY PDSVKGRFTI SRDNVKNTLY LQMSSLRSED TAMYYCARRD 100

YDLDYFDSWG QGTLVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD 150

YFPEPVTVSW NSGALTSGVH TFPAVLQSSG LYSLSSVVTV PSSSLGTQTY 200

ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP SVFLFPPKPK 250

DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS 300

TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV 350

YTLPPSRDEL TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL 400

DSDGSFFLYS KLTVDKSRWQ QGNVFSCSVM HEALHNHYTQ KSLSLSPGK  449

Light chain / Chaone lygire / Cadena ligera

DIQMTQSPSS LSASVGDRVT ITCKASRDIR SYLTWYQQKP GKAPKTLIYY  50

ATSLADGVPS RFSGSGSGQD YSLTISSLES DDTATYYCLQ HGESPFTLGS 100

GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV 150

DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG 200

LSSPVTKSFN RGEC                                        214

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	146-202	263-323	369-427

	22??-96??	146??-202??	263??-323??	369??-427??

Intra-L	23?-88?	134?-194?



	23???-88???	134???-194???



Inter-H-L	222-214?	222??-214???



Inter-H-H	228-228??	231-231??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

299, 299??

CAS		1116433-11-4

Description

immunoglobulin G1-kappa, anti-[Homo sapiens CD6 (Tp120, T12)], humanized
monoclonal antibody;

gamma1 heavy chain (1-449) [humanized VH (Homo sapiens IGHV3-21*08
(83.70%) -(IGHD)-IGHJ5*01) [8.8.12] (1-119) -Homo sapiens IGHG1*01
(120-449)], (222-214?)-disulfide with kappa light chain (1'-214')
[humanized V-KAPPA (Homo sapiens IGKV1-17*01 (76.80%) -IGKJ2*01 F118>L,
Q120>S) [6.3.9] (1?-107?) -Homo sapiens IGKC*01 (108?-214?)];
(228-228":231-231")-bisdisulfide dimer 

immunoglobuline G1-kappa, anti-[Homo sapiens CD6 (Tp120, T12)],
anticorps monoclonal humanisy; 

chaone lourde gamma1 (1-449) [VH humanisy (Homo sapiens IGHV3-21*08
(83.70%) -(IGHD)-IGHJ5*01) [8.8.12] (1-119) -Homo sapiens IGHG1*01
(120-449)], (222-214?)-disulfure avec la chaone lygire kappa (1'-214')
[V-KAPPA humanisy (Homo sapiens IGKV1-17*01 (76.80%) -IGKJ2*01 F118>L,
Q120>S) [6.3.9] (1?-107?) -Homo sapiens IGKC*01 (108?-214?)]; dimire
(228-228":231-231")- bisdisulfure 

inmunoglobulina G1-kappa, anti-[Homo sapiens CD6 (Tp120, T12)],
anticuerpo monoclonal humanizado;

cadena pesada gamma1 (1-449) [VH humanizado (Homo sapiens IGHV3-21*08
(83.70%) -(IGHD)-IGHJ5*01) [8.8.12] (1-119) -Homo sapiens IGHG1*01
(120-449)], (222-214?)-disulfuro con la cadena

ligera kappa (1?-214?) [V-KAPPA humanizado (Homo sapiens IGKV1-17*01
(76.80%) -IGKJ2*01 F118>L, Q120>S) [6.3.9] (1?-107?) -Homo sapiens
IGKC*01 (108?-214?)]; dnmero (228-228":231-231")-

bisdisulfuro

	

WHO 

International Nonproprietary Names Programme	

30/06/2010

9321



		

